LIBRISTO
LIBROAMANTO
obvezno
Postanite del skupnosti ljubiteljev knjig z vsega sveta in uživajte v številnih ugodnostih. Ustvarite brezplačen račun
0
Brezplačna dostava Zásilkovna nad 69.99 €
Zbirna točka GLS 4.49 Zbirna točka DPD 2.99 Kurirska služba GLS 5.49 Kurir DPD 3.49 Kurirska služba 3.49 Zbirno mesto 3.49 Zbirno mesto 3.49 Dostava preko Pošte Slovenije 3.49

Brezplačna dostava za naročila nad 69.99 € na paketomatih Pošte Slovenije.
Jezik AngleščinaAngleščina
E-knjiga Adobe ePub DRM
E-knjiga Genome-Based Diagnostics Institute of Medicine
Koda Libristo: 39658426
Založba National Academies Press, junij 2012
The sequencing of the human genome and the identification of associations between specific genetic v... Celoten opis
? points 89 b
36.98
Na zalogi Prenesi zdaj

The sequencing of the human genome and the identification of associations between specific genetic variants and diseases have led to an explosion of genomic-based diagnostic tests. These tests have the potential to direct therapeutic interventions, predict risk or onset of disease, or detect residual disease. As research progresses and an increasing number of associations are found, further tests will be developed that can aid in providing personalized treatment options for patients. However, the adoption of genomic diagnostic tests by health care providers has been limited due to a lack of evidence regarding the clinical utility of many tests. Health funders and practitioners lack the data necessary to distinguish which tests can improve practice or the clinical settings in which tests will provide the greatest value. The Roundtable on Translating Genomic-Based Research for Health held a workshop in November 2010 to determine what evidence is needed and how it is viewed by different stakeholders in order to develop genomic diagnostic tests of clinical value.Genome-Based Diagnostics summarizes the presentations and discussions that took place throughout the workshop. Two presentations, in particular, sparked extensive discussion. One presentation proposed that all genomic diagnostic tests be reviewed and approved by the Food and Drug Administration. The other observed that venture capitalists are no longer investing substantially in the development of genomic diagnostic tests because of a lack of clarity surrounding regulatory and reimbursement pathways. Both presentations suggested the need for major changes in the systems used to develop, regulate, and reimburse genomic diagnostic tests. The report also presents the perspectives of different stakeholders in the development of genomic diagnostic tests. Each stakeholder group has a different set of needs and issues of importance, yet commonalities among them are apparent, such as the need to put patients and health outcomes at the center of discussion and action.

Igralka & Poliglotka
EWA KASP za
Predvajaj video
Ewa Kasp
Libristo ima največjo izbiro tujejezične literature. Zato svoje knjige kupujem tukaj.
Podarite to knjigo še danes
To je povsem preprosto
1 Dodajte knjigo v košarico in izberite dostavo kot darilo 2 V zameno vam bomo poslali kupon 3 Knjiga bo dostavljena na naslov obdarovanca

Prijava

Prijavite se v svoj račun. Še nimate računa Libristo? Ustvarite ga zdaj!

 
obvezno
obvezno

Še nimate računa? Izkoristite prednosti računa Libristo!

Z računom Libristo boste imeli vedno vse pod nadzorom.

Ustvarite račun Libristo
Knjižni svetovalec Libroamiko
Pozdravljeni, sem Libroamiko, vam lahko pomagam?